Correction to: Conversion of quinazoline modulators from inhibitors to activators of β-glucocerebrosidase (Journal of Medical Chemistry (2019) 62: 3 (1218-1230) DOI: 10.1021/acs.jmedchem.8b01294)

Jianbin Zheng, Sohee Jeon, Weilan Jiang, Lena F. Burbulla, Daniel Ysselstein, Kristine Oevel, Dimitri Krainc, Richard B. Silverman

Research output: Contribution to journalComment/debate

Abstract

Page 1228. In the right column, line 22 from the top, "400 μM" should be "400 nM".

Original languageEnglish (US)
Number of pages1
JournalJournal of Medicinal Chemistry
Volume62
Issue number5
DOIs
StatePublished - Mar 14 2019

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint Dive into the research topics of 'Correction to: Conversion of quinazoline modulators from inhibitors to activators of β-glucocerebrosidase (Journal of Medical Chemistry (2019) 62: 3 (1218-1230) DOI: 10.1021/acs.jmedchem.8b01294)'. Together they form a unique fingerprint.

  • Cite this